Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK SARA LISA DOKTOR ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   2.4% 1.1% 1.6% 3.0% 2.7% 3.2% 10.0% 9.8%   Credit score (0-100)   66 85 75 56 60 54 25 25   Credit rating   BBB A A BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 167.5 10.1 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,095 2,085 932 660 697 688 0.0 0.0   EBITDA   173 1,352 294 -148 40.2 -170 0.0 0.0   EBIT   133 1,337 223 -219 -30.8 -271 0.0 0.0   Pre-tax profit (PTP)   100.8 1,322.5 198.0 -236.5 -63.4 -338.0 0.0 0.0   Net earnings   74.5 1,021.5 146.1 -224.2 -21.9 -294.8 0.0 0.0   Pre-tax profit without non-rec. items   101 1,323 198 -237 -63.4 -338 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   160 343 272 201 130 486 0.0 0.0   Shareholders equity total   2,857 3,808 3,914 3,643 3,564 3,210 3,024 3,024   Interest-bearing liabilities   672 149 113 387 759 1,370 0.0 0.0   Balance sheet total (assets)   3,730 4,319 4,176 4,165 4,375 4,692 3,024 3,024   Net Debt   617 93.7 -16.4 332 704 1,315 -3,024 -3,024     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,095 2,085 932 660 697 688 0.0 0.0   Gross profit growth   8.8% 90.4% -55.3% -29.1% 5.5% -1.3% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   3,730 4,319 4,176 4,165 4,375 4,692 3,024 3,024   Balance sheet change%   -2.9% 15.8% -3.3% -0.3% 5.0% 7.2% -35.5% 0.0%   Added value   173.0 1,352.5 293.6 -147.8 40.2 -169.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   48 168 -142 -142 -142 254 -486 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   12.1% 64.1% 23.9% -33.1% -4.4% -39.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.5% 33.2% 5.2% -5.2% -0.7% -6.0% 0.0% 0.0%   ROI %   3.7% 35.7% 5.6% -5.4% -0.7% -6.1% 0.0% 0.0%   ROE %   2.5% 30.7% 3.8% -5.9% -0.6% -8.7% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   76.6% 88.2% 93.7% 87.5% 81.5% 68.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   356.5% 6.9% -5.6% -224.7% 1,749.7% -775.7% 0.0% 0.0%   Gearing %   23.5% 3.9% 2.9% 10.6% 21.3% 42.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   5.4% 3.6% 18.7% 7.1% 5.7% 6.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.4 1.3 2.9 1.4 1.0 0.4 0.0 0.0   Current Ratio   0.4 1.3 2.9 1.4 1.0 0.4 0.0 0.0   Cash and cash equivalent   54.9 54.9 129.9 54.9 54.9 54.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -581.0 115.3 441.5 179.5 -85.1 -1,002.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   173 1,352 294 -148 40 -170 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   173 1,352 294 -148 40 -170 0 0   EBIT / employee   133 1,337 223 -219 -31 -271 0 0   Net earnings / employee   74 1,022 146 -224 -22 -295 0 0